Department of Orthopaedic Surgery, University of Minnesota Medical School, Minneapolis, MN.
Department of Orthopaedic Surgery, University of Minnesota Medical School, Minneapolis, MN; Department of Orthopaedics, TRIA Orthopaedics Center, Bloomington, MN; Department of Orthopaedic Surgery, Methodist Hospital, St. Louis Park, MN.
J Arthroplasty. 2020 Jun;35(6S):S163-S167. doi: 10.1016/j.arth.2020.03.001. Epub 2020 Mar 5.
Total knee arthroplasty (TKA) creates a relatively large degree of nociception, making it a good setting to study variation in pain intensity and pain alleviation. The purpose of this study is to investigate factors associated with a second prescription of opioid medications within 30 days of primary TKA.
Using an insurance database, we studied 1372 people over a 6-year period with no mental health comorbidities including substance misuse and no comorbid pain illness at the time of TKA. Factors associated with a second prescription of opioid medication within 30 days of TKA were sought among patient demographics and the overall prescription morphine milligram equivalents. Patient and prescription-related risk factors were evaluated utilizing logistic relative risk regression. We reserved a year of data, 222 people, to evaluate the performance of the derived model.
More than half the patients filled a second prescription for opioids within 30 days of TKA. Factors associated with a second prescription of opioid medication within 30 days of TKA included age (P < .01), current smoker (P = .01), and the total morphine milligram equivalents of the initial prescription (P < .01). Applied to the 222 people we reserved for validation, the model was 81% sensitive and 14% specific for a second prescription within 30 days, with a positive predictive value of 74%, and a negative predictive value of 20%.
People that are given more opioids tend to request more opioids, but our model had limited diagnostic performance characteristics indicating that we are not accounting for the key factors associated with a second opioid prescription. Future studies might address undiagnosed patient social and mental health opportunities, factors known to associate with pain intensity and satisfaction with pain alleviation.
Diagnostic Level III.
全膝关节置换术(TKA)会产生较大程度的伤害感受,因此是研究疼痛强度和缓解变化的良好环境。本研究旨在调查与初次 TKA 后 30 天内再次开处阿片类药物相关的因素。
我们使用一个保险数据库,对 6 年期间无精神共病(包括药物滥用)且初次 TKA 时无并存疼痛疾病的 1372 人进行了研究。在患者人口统计学和总体处方吗啡毫克当量中寻找与初次 TKA 后 30 天内再次开处阿片类药物相关的因素。利用逻辑相对风险回归评估患者和处方相关的风险因素。我们保留了一年的数据,即 222 人,以评估所推导模型的性能。
超过一半的患者在初次 TKA 后 30 天内再次开处阿片类药物处方。与初次 TKA 后 30 天内再次开处阿片类药物处方相关的因素包括年龄(P<.01)、当前吸烟者(P=.01)和初始处方的总吗啡毫克当量(P<.01)。应用于我们保留用于验证的 222 人,该模型对 30 天内再次开处处方的敏感性为 81%,特异性为 14%,阳性预测值为 74%,阴性预测值为 20%。
给予更多阿片类药物的人往往会要求更多的阿片类药物,但我们的模型具有有限的诊断性能特征,表明我们没有考虑与再次开处阿片类药物处方相关的关键因素。未来的研究可能会针对未确诊的患者的社会和心理健康机会,以及已知与疼痛强度和疼痛缓解满意度相关的因素进行研究。
诊断 III 级。